Kringle Pharma, Inc.

4884.T

JPXHealthcareBiotechnology

Open in GoAI

Latest quote

¥433

+¥3.00 · +0.70%

Aug 24, 3:30 PM JST

Regular session · JST · Market data may be delayed.

Company profile

Company website

Kringle Pharma, Inc. specializes in the innovation, production, and distribution of hepatocyte growth factor (HGF) protein-based therapeutics aimed at regenerative medicine. The company's cutting-edge HGF solutions are designed to address serious medical conditions including acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scars, and acute kidney injury. Founded in 2001, Kringle Pharma operates from its base in Ibaraki, Japan.

Industry: Biotechnology
Sector: Healthcare
Headquarters: JP
CEO: Kiichi Adachi
Listed since: Dec 28, 2020
Employees: 17